Kelly DL - Search Results

1

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

Lee MR, Wehring HJ, McMahon RP, Linthicum J, Cascella N, Liu F, Bellack A, Buchanan RW, Strauss GP, Contoreggi C, Kelly DL. Lee MR, et al. Among authors: kelly dl. Schizophr Res. 2013 Apr;145(1-3):110-5. doi: 10.1016/j.schres.2013.01.001. Epub 2013 Feb 13. Schizophr Res. 2013. PMID: 23415472 Free PMC article. Clinical Trial.

2

Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.

Conley RR, Kelly DL, Gale EA. Conley RR, et al. Among authors: kelly dl. Schizophr Res. 1998 Sep 7;33(1-2):95-101. doi: 10.1016/s0920-9964(98)00062-0. Schizophr Res. 1998. PMID: 9783349

3

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: kelly dl. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

4

Circumstances of suicide among individuals with schizophrenia.

Kreyenbuhl JA, Kelly DL, Conley RR. Kreyenbuhl JA, et al. Among authors: kelly dl. Schizophr Res. 2002 Dec 1;58(2-3):253-61. doi: 10.1016/s0920-9964(01)00379-6. Schizophr Res. 2002. PMID: 12409166

5

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Conley RR, et al. Among authors: kelly dl. Ann Clin Psychiatry. 2003 Mar;15(1):23-31. doi: 10.1023/a:1023276509470. Ann Clin Psychiatry. 2003. PMID: 12839430

6

Deaths from diabetic ketoacidosis after long-term clozapine treatment.

Wehring HJ, Kelly DL, Love RC, Conley RR. Wehring HJ, et al. Among authors: kelly dl. Am J Psychiatry. 2003 Dec;160(12):2241-2. doi: 10.1176/appi.ajp.160.12.2241-a. Am J Psychiatry. 2003. PMID: 14638600 No abstract available.

7

Atypical antipsychotic use in a state hospital inpatient adolescent population.

Kelly DL, Love RC, MacKowick M, McMahon RP, Conley RR. Kelly DL, et al. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):75-85. doi: 10.1089/104454604773840517. J Child Adolesc Psychopharmacol. 2004. PMID: 15142394

8

Cardiovascular disease in relation to weight in deceased persons with schizophrenia.

Conley RR, Shim JC, Kelly DL, Feldman S, Yu Y, McMahon RP. Conley RR, et al. Among authors: kelly dl. Compr Psychiatry. 2005 Nov-Dec;46(6):460-7. doi: 10.1016/j.comppsych.2005.03.007. Compr Psychiatry. 2005. PMID: 16275214

9

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757

10

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.

McMahon RP, Kelly DL, Boggs DL, Li L, Hu Q, Davis JM, Carpenter WT Jr. McMahon RP, et al. Among authors: kelly dl. Schizophr Bull. 2008 Mar;34(2):292-301. doi: 10.1093/schbul/sbm152. Epub 2008 Jan 8. Schizophr Bull. 2008. PMID: 18184634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters